SUBSCRIPTION AGREEMENTSubscription Agreement • May 1st, 2017 • DanDrit Biotech USA, Inc. • Pharmaceutical preparations • Delaware
This SUBSCRIPTION AGREEMENT (this “Subscription Agreement”) is made by and between DanDrit Biotech USA, Inc. a Delaware corporation (the “Company”), and the undersigned (“Subscriber”) as of the date this Subscription Agreement is accepted by the Company, as set forth on the Company’s signature page hereto.
THIS WARRANT AND THE SHARES ISSUABLE UPON THE EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. EXCEPT AS OTHERWISE SET FORTH HEREIN NEITHER THIS WARRANT NOR ANY OF SUCH SHARES MAY BE SOLD, TRANSFERRED OR...Warrant Agreement • May 1st, 2017 • DanDrit Biotech USA, Inc. • Pharmaceutical preparations • Delaware
THIS Common Stock Purchase Warrant CERTIFIES THAT, for value received, [_______________], or its registered assigns, (“Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 PM Eastern Standard Time on [_______________] (the “Expiration Date”) but not thereafter, to subscribe for and purchase from DanDrit Biotech USA, Inc., a Delaware corporation with offices at Fruebjergvej 3 Box 62, 2100 Copenhagen, Denmark (the “Company”) an aggregate of up to [________] shares of common stock, par value $0.0001 per share, of the Company (the “Shares”), at a price per Share specified herein, as adjusted in accordance with Section 2 below (the “Purchase Price”).
